baber/WOPTO huggingface dataset:
Patent PT-721532-E (PT)
Inventor: MELBY JEFFREY A
IPC: E02B3/12
Filed: 1994-08-17
Abstract: A concrete armor or erosion prevention module for the protection of river, lake, and reservoir banks, shorelines and other structures is characterized by a central elongate concrete member and two outer elongate concrete members connected on opposites sides of the central member. The outer members have parallel longitudinal axes extending normal to the longitudinal axis of the central member. These elongate members all have an octagonal cross-section and are further configured such that their cross-sectional area decreases from an intermediate portion towards opposite ends thereof. A plurality of the modules may be interlocked to form a cohesive array or barrier which protects shorelines and other structure from erosive hydrodynamic forces.
Patent PT-755633-E (PT)
Inventor: SCHLACHTER HERBERT
IPC: A23L33/10
Filed: 1995-07-28
Abstract: The invention concerns a preparation designed to act gradually and containing a product A for the first stage and a product B for the second stage. Each of the products includes, independently of each other, at least one unsaturated fatty acid and/or at least one trace element or mineral and/or at least one vitamin and/or at least one bioactive plant substance, e.g. a polyphenol, biflavonoid or dietary fibre, and/or at least one amino acid and/or amino-acid derivative, product A and/or product B optionally also containing soya lecithin, with the provision that product A and product B differ from each other in their amounts and/or their material composition. The preparation can be used as a dietary complement or as a drug.
Patent PT-739355-E (PT)
Inventor: WILLIAM MARKLAND
IPC: C07K14/81
Filed: 1995-01-11
Abstract: Proteins are disclosed that are homologous to bovine pancreatic trypsin inhibitor (BPTI) Kunitz domains, and especially proteins that are homologous to lipoprotein-associated coagulation inhibitor (LACI) Kunitz domains, which inhibit one or more plasma and/or tissue kallikreins, and uses of such proteins in therapeutic and diagnostic methods also are disclosed. In particular, Kunitz domains derived from Kunitz domains of human origin and especially to the first Kunitz domain of LACI are disclosed.
Patent PT-804616-E (PT)
Inventor: BERGERON MICHEL G
IPC: C12Q1/689
Filed: 1995-09-12
Abstract: The present invention relates to DNA-based methods for universal bacterial detection, for specific detection of the pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Streptococcus pneumoniae, Staphylococcus aureus, Staphylococcus epiderminis, Enterococcus faecalis, Staphylococcus saprophyticus, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis as well as for specific detection of commonly encountered and clinically relevant bacterial antibiotic resistance genes directly from clinical specimens or, alternatively, from a bacterial colony. The above bacterial species can account for as much as 80% of bacterial pathogens isolated in routine microbiology laboratories. The core of this invention consists primarily of the DNA sequences from all species-specific genomic DNA fragments selected by hybridization from genomic libraries or, alternatively, selected from data banks as well as any oligonucleotide sequences derived from these sequences which can be used as probes or amplification primers for PCR or any other nucleic acid amplification methods. This invention also includes DNA sequences from the selected clinically relevant antibiotic resistance genes.
Patent PT-860320-E (PT)
Inventor: JENSEN KNUD
IPC: B60P1/44
Filed: 1997-02-20
Abstract: The system has a lifting/fold-down mechanism (12) for a tailgate (15) to lift/lower a load, with lifting cylinder unit (16) and tilting cylinder unit (17). The tilting cylinder unit is constructed so that pivoting of the tailgate from horizontal to vertical position takes place at a first preselected speed v1 within a preset first angle interval (150), and at a second preselected speed v2 within a second interval (151), with v1 being smaller than v2.
Patent PT-814183-E (PT)
Inventor: CHAVANNES JEAN-PIERRE
IPC: C09K3/10
Filed: 1997-06-18
Abstract: Aluminium oxide sealant compositions, concentrates, and processes employing the same are described which comprise a combination of certain sulphonated aromatic compounds and condensates of aldehydes and certain other sulphonated aromatic compounds. Unexpected improvements in seal quality are obtained using the compositions of the invention, and in the substantial absence of smut formation.
Patent PT-876152-E (PT)
Inventor: THOMAS GRIFFITH R
IPC: A61P7/00
Filed: 1997-01-13
Abstract: The present invention is directed to the surprising and unexpected finding that biologically active thrombopoietin materials can be administered with substantial therapeutic effect at dosage rates commensurate with previously reported administration of such materials, but in a single or low-multiple daily administration. Thus, the predicate of the present invention relates to the reversal of thrombocytopenia by administering to a patient having or in need of such treatment a single or low-multiple daily dose of a therapeutically effective amount of a thrombopoietin. The preferable dose of the active material ranges from about 1 to about 10  mu g/kg body weight.
Patent PT-904614-E (PT)
Inventor: PELISSIE FRANCIS
IPC: H01R43/048
Filed: 1997-06-11
Abstract: A device for crimping a series of metal lugs on electric wires with an insulating sheath of which one end has been partially stripped off, wherein each crimping block (6) is secured to a plate (1) by releasable attachment means (26, 27); and each crimping die (8) is secured to the tool holder (2) by releasable attachment means (18), said releasable attachment means (18, 26, 27) being suitable for attaching one or more blocks (6) and matrices (8) having a variety of shapes and/or sizes. A tool assembly (21) for use with such a crimping device is also disclosed.
Patent PT-854424-E (PT)
Inventor: SCHNEIDER XAVIER
IPC: B61C17/04
Filed: 1998-01-12
Abstract: The system has a part (1,9) which sends information to a screen (6). The displayed information is read (11) and compared (10) with the sent information. The display operation is interrupted if the displayed and sent information do not concur. The screen is the active portion only of a flat transparent display with an active surface having electronic control. The reader is an optical sensor which is positioned at the back of the screen in relation to the observer (12) and consists of a linear charge transfer detector connected to the rear face of the screen by an optical fibre network. The information fed to the screen passes along two separate channels (3,4), one passing through the screen's video input (5) and the other through the comparison unit.
Patent PT-958473-E (PT)
Inventor: JENSEN GAUTE
IPC: F17C1/02
Filed: 1998-01-27
Abstract: Pressure container for fluids, such as propane and butane, comprinsing an inner, fluid-tight liner layer (1) and a pressure supporting layer (2) outside the liner, as well as an outer, protective casing (5). As known per se the said layers (1, 2) consist of transparent or translucent materials, and the casing (5) comprises a middle section (7) having surface portions (7A, 7B, 7C) being cut-away so that parts of the actual container (3), being located inside the casing (5), are visible from the outside, and that the casing has shock-absorbing properties.
Patent PT-970121-E (PT)
Title: Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis
Inventor: CATZ INGRID
IPC: A61K38/08
Filed: 1998-04-03
Abstract: Human myelin basic protein (h-MBP) has a molecular weight of 18.5 KD and contains 170 amino acid residues. Synthetic peptides ranging in length from about 8 to 25 residues and covering the entire length of the protein have been produced. Antibodies to h-MBP (anti-MBP) were found to be neutralized by the synthetic peptides, in vitro, which span the h-MBP from about amino acid residue 61 to about amino acid residue 106. The peptides, which cover both the amino (about residues 1 to 63) and carboxy (about residues 117 to 162) terminals of h-MBP did not neutralize purified anti-MBP. Intrathecal administration of peptide MBP(75-95), MBP(86-95), or MBP(82-98) produced complete binding-neutralization of free (F) anti-MBP with no change in bound (B) levels. A control peptide MBP(35-58) had no effect on (F) or (B) anti-MBP levels. Intravenous administration of MBP(75-95), MBP(86-95), or MBP(82-98) resulted in significant decline of (F) and (B) CSF anti-MBP levels. Administration of MBP synthetic peptides to MS patients either intrathecally or intravenously did not have any adverse neurological effects and systemic complications did not occur. The MBP epitope for MS anti-MBP has been localized to an area between Pro86 and Pro95.
Patent PT-939170-E (PT)
IPC: E03D1/012
Filed: 1999-02-26
Abstract: The system has a mounting frame (14) and a container (10) for intermediate storage of a prespecified quantity of water of between 5 and 10 litres. An attachment (18) is provided for a toilet bowl or dish. The frame has mounting elements (12) for a unit on the walls of a 90 degree chamber corner. The attachment is provided on the frame whose width (B) is set by the rear width of the toilet bowl. The design of the container is suited to the space provided by the installation of the frame. The mounting depth (T) of the frame is preferably 20 to 23 cm; The width (B) of the frame is preferably 24 to 40 cm; and the height of the frame is preferably 90 to 105 cm.
Patent PT-1108425-E (PT)
Inventor: MENDES CARLA PATRICIA GONCALVE
IPC: A61K31/4184
Filed: 1999-12-16
Abstract: The present invention relates to new oral multi-unitary pharmaceutical preparations containing substituted benzimidazoles being inhibitors of H<+>, K<+>-ATPase (i.e. omeprazole, lansoprazole, pantoprazole, leminoprazole and pariprazole) or their pharmaceutically acceptable salts. Such pharmaceutical preparations are stable pellet preparations containing substituted benzimidazole(s) or their salts and they comprise a quantity of active ingredient of between I and 50 mg, an inert core of spherical symmetry with a diameter of 600 - 1000  mu m, constituted by inert excipients, coated with an active layer containing at least one substituted benzimidazole in the micronized form and various pharmaceutically acceptable inert excipients, mixed in suitable proportions in order to allow the disaggregation of the formulations and dissolution of the active ingredient(s) in an appropriate manner, coated in turn with an insulating layer of a strictly polymeric nature, soluble in water, free from alkaline and/or alkaline-earthy metallic salts, of a minimum thickness of 15  mu m, this layer being coated lastly with a gastroresistant or enteric layer of a minimum thickness of 30  mu m. This invention also refers to the process for the preparation of said pharmaceutical preparations.
Patent PT-1137937-E (PT)
Title: Using hair for detecting breast cancer, prostate cancer or alzheimer disease
Inventor: JAMES VERONICA
IPC: G01N33/483
Filed: 1999-12-10
Abstract: A method for detecting the presence of a gene responsible for a pathological state; or the pathological state itself in a patient comprising exposing at least one hair from the patient to fibre X-ray diffraction and detecting changes in the ultrastructure of the hair. An instrument (1) for detecting the presence of a gene responsible for a pathological state; or de pathological state itself, using a hair sample, comprising: an X-ray source (2) producing a beam of X-ray radiation; a sample stage for positioning said hair (3) sample within said beam; a detector to detect the scanering of said X-ray beam caused by said hair sample; and a display means (9) associated with said detector for displaying the output thereof (9a, 9b, 9c and 9d); whereby patterns of output related to the presence of said gene or said pathological state are displayed for interpretation.
Patent SG-41791-G (SG)
Title: Improvements in or relating to ink systems
IPC: B41K3/60
Filed: 1991-06-03
Abstract: An inker guard having a stamp-ink container for franking and value-stamping machines is described, which covers the different chambers of the inking system in such a way that even at high rotational speeds, spraying of stamp ink from one chamber to an adjacent chamber is prevented. Moreover, the feeding of stamp ink via cartridges which can be inserted into the guard offers a simple and clean procedure without opening the inking system.
Patent SG-47393-G (SG)
Title: Downhole memory gauge
IPC: E21B47/00
Filed: 1993-04-16
Abstract: A downhole self-contained memory gauge includes either a semiconductor or magnetic core memory for retaining downhole information related to sampled parameters, such as borehole temperature and pressure. A microprocessor-based computer manages the power utilization by independently and selectably energizing and de-energizing different sections of the gauge. The magnetic core memory is tested for operability, and the addressing of the magnetic core memory is adjusted in accordance with any inoperable memory locations. Samples of the monitored environmental conditions can be taken at variable rates dependent upon software monitoring of the condition, the remaining battery life and the remaining memory capacity and in response to hardware monitored pressure changes. Each sample can be taken to a selectable resolution. A watchdog circuit monitors the microprocessor to ensure that it is operating within a preselected time limit.
Patent IE-800014-L (IE)
Title: Tetrahydroquinoline-2-carboxylic acids
IPC: C07D215/48
Filed: 1980-01-04
Abstract: A series of 1-[acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids and salts thereof are useful as Angiotensin I converting enzyme inhibitors.
[US4461896A]
Patent IE-830066-L (IE)
Title: Manually operated labeler
IPC: B65C11/00
Filed: 1983-01-13
Abstract: An apparatus is described by which a label bearing tape can be transported intermittently in a manually operated labeler. The device contains a transporting carriage (19) reciprocable along the label bearing tape (5). In the carriage a latch (22) with a clamping face (25) is held in frictional engagement with the label bearing tape so that during movement of the carriage in one direction it freely slides on the label bearing tape, while during movement of the carriage in the other direction it clamps the label bearing tape against an abutment surface (26) with self-locking action. The clamping face of the latch is covered with abrasive paper, preferably with an aluminous abrasive paper.
[US4544433A]
Patent IE-900145-L (IE)
Title: Fungicides
IPC: C07C255/64
Filed: 1990-01-12
Abstract: Fungicidal compounds of the formula (I): <CHEM> in which A and B are independently H, fluoro, chloro, bromo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl provided that both are not H; D and E are independently H or fluoro; R<1> is H, C1-4 alkyl or C1-4 alkoxy; R<2> is C1-4 alkyl, C1-4 alkoxy or optionally substituted phenyl, or R<1> and R<2> together with the nitrogen atom to which they are attached join to form a morpholine, piperidine, pyrrolidine or azetidine ring which is optionally substituted with C1-4 alkyl; R<3> is H; R<4> is trichloromethyl, C2-8 alkyl (optionally substituted with halogen, C1-8 alkoxy or R min S(O)n in which R min is C1-4 alkyl, C2-4 alkenyl or C2-4 alkynyl and n is 0, 1 or 2), cyclopropyl (optionally substituted with halogen or C1-4 alkyl), C2-8 alkenyl, C2-8 alkynyl, C1-8 alkoxy, mono- or di(C1-4)alkyl- amino or the group, R sec ON=C(CN) in which R sec is C1-4 alkyl, or R<3> and R<4> together with the group C(O)N to which they are attached join to form an azetidin-2-one ring which is optionally substituted with halogen or C1-4 alkyl; and X and Y are independently oxygen or sulphur.
[EP0381330A1]
Patent IE-33995-L (IE)
Title: Bornanecarboxamides
IPC: C07C303/36
Filed: 1970-02-09
Abstract: 1,263,404. Sulphonyl-carbamoyl bornanes. F. HOFFMAN-LA ROCHE & CO. A.G. 11 Feb., 1970 [14 Feb., 1969; 12 June, 1969], No. 6452/70. Heading C2C. Novel Compounds I (including racemates and optically active isomers, and salts thereof) where R is H or Me, R<SP>1</SP> is H and R<SP>2</SP> is OH or R<SP>1</SP> and R<SP>2</SP> taken together signify the oxygen of a keto group (which can be ketalized including cyclic ketals), and R<SP>3</SP> is phenyl which can be substituted by halogen, alkyl, alkoxy, alkylthio, amino, acylamino, acylamino-alkyl, CN, carbamoyl or diacylimido, or is cycloalkyl or a 5- or 6- membered N-linked nitrogen containing heterocyclic residue are made according to standard methods. Pharmaceutical preparations showing hypoglycaemic action contain I as active ingredient; administration is in the form of, e.g. tablets, dragees, suppositories or capsules.
[GB1263404A]
Patent IE-830186-L (IE)
Title: Purines
IPC: C07D/
Filed: 1983-01-31
Abstract: EP--85424 A (A) 9-(2-acyloxy-1-hydroxymethyl ethoxymethyl) purine derivs. of formula (I) and their acid-addn. salts are new, (R1 is H or R7CO; R7 is H, 1-19C alkyl, 1-8C hydroxyalkyl, 2-9C alkoxyalkyl, 2-19C alkenyl, Ph, 1-adamantyl, 2-carboxyethyl, or carboxymethyl or their alkali metal salts; R2 is R7CO; R3 is H, halogen, SH, 1-6C alkylthio, N3, NR9R19 or NH-COR8; R8 is H, 1-19C alkyl or 1-adamantyl; R9 and R10 are H or 1-6C alkyl; and either (a) R4+R5 form a single bond and R6 is H, halogen, 1-6C alkoxy, N3, SH, 1-6C alkylthio, NR9R10 or NH-COR8; or (b) R4 is H and R5+R6 form a keto group). (B) Intermediates of formula (I) are new when (1) R1 and R2 are H; R3 is other than NY-COR8; R4 and R5 form a bond and R6 is other than NH-COR8; and (2) R1, R2 and R4 are H; R3 is NH-COR8; and R5+R6 form a keto gp. - Cpds. (I) are antivirals esp. effective against Herpes simplex virus I and II, cytomegalovirus, Epstein-Barr virus and varicella zoster virus and viral hepatitis B. Intermediates defined in paragraph (B) are also antivirals. Dose is 0.1-300 mg/kg. orally or parenterally. (0/0) USAB- US4612314 A Substd. 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines of formula (I) are new. In (I), R1 and R2 are both -C(O)R7 in which R7 is 1-adamantyl; R3 is NH2 a R6 is H or NH2 and R4 with R5 is a bond or b R5 with R6 is keto and R4 is H. Esp. cpd. is 9-(1,3-di(1-adamantyl carboxy)-2-propoxy methyl)guanine. (I) may be prepd. e.g. by esterifying cpds. (X) and (IV).
[ES8601991A1]
Patent IE-44525-L (IE)
Title: Hydrophilic filaments
IPC: D01F6/54
Filed: 1977-03-09
Abstract: The invention relates to a process for the production of hydrophilic filaments and fibers which comprises wet- or dry-spinning a fibre-forming synthetic polymer from a spinning solvent containing from 5 to 50% of a substance which has a higher melting or boiling point than the spinning solvent which is miscible with the spinning solvent and with a liquid suitable for use as a washing liquid and which is a non-solvent for the polymer to be spun and from 0,1 to 20% by weight of at least one substance which decomposes into a gas under heating.
[US4185059A]
Patent IE-840569-L (IE)
Title: Process for preparing dialkyl propanediimidate¹dihydrohalides
IPC: C07C257/04
Filed: 1984-03-09
Abstract: An improved process for preparing a dialkyl propanediimidate dihydrohalide by reacting malononitrile, an alcohol, and hydrogen halide, wherein the improvement comprises conducting the reaction under greater than atmospheric pressure in a halobenzene, haloalkylbenzene or alkylbenzene solvent.
Patent IE-780809-L (IE)
Title: Electrolytic deposition of metals.
IPC: H01M8/22
Filed: 1978-04-24
Abstract: Process for the assembling at least one support, at least part of the surface of which conducts electrons, with at least one electrically insulating membrane, said membrane having pores at least part of which are open pores, is improved by causing an electrolytic depositing of at least one metal in a part of the open pores, said electrolytic deposit adhering to at least a part of the electron-conductive surface of the support.
[US4211829A]
Patent IE-870869-L (IE)
Title: Amlodipine (pyridine derivatives) benzenesulphonate
IPC: A61K31/44
Filed: 1987-04-03
Abstract: Improved pharmaceutical salts of amlodipine, particularly the besylate (benzyl sulphonate) salt, and pharmaceutical compositions thereof. This salt finds utility as an anti-ischaemic and anti-hypertensive agent.
[GB2188630A]
Patent IE-810925-L (IE)
Title: Organic complex of platinum.
IPC: A61P35/00
Filed: 1981-04-24
Abstract: An organic complex of platinum, cis-isocitrato (1,2 diaminocyclohexane) platinum (II) having improved anti-tumor activity and water-solubility. The complex is prepared by reacting cis-dichloro (1,2-diaminocyclohexane) platinum (II) with silver nitrate, removing the silver chloride formed, and reacting the resulting liquid with trisodium isocitrate. The complex is administered in the form of a pharmaceutical composition.
[US4452812A]
Patent IE-861011-L (IE)
Title: Control of dental plaque and caries
IPC: A61K8/34
Filed: 1986-04-17
Abstract: Plaque is inhibited and oral hygiene promoted including reduction in caries formation by dispersing emulsan in water and contacting the aqueous dispersion with dental surfaces. Emulsan may be dispersed in dental preparation toothpaste or mouthwash.
[US4619825A]
Patent IE-37862-L (IE)
Title: Tert. butyl 4-tert. butyl perbenzoate
IPC: C08F4/34
Filed: 1973-07-02
Abstract: Process for manufacturing tertiarbutyl p-tertiarybutyl perbenzoate at least 99 percent pure. The process consists in reacting 4-tertiarybutyl benzoic acid chloride with an alkaline solution of a tertiarylbutyl peroxide salt at a temperature comprised between 40 DEG and 45 DEG C possibly in the presence of a surfactant.
[US3869489A]
Patent IE-43961-L (IE)
Title: Acid salt solutions
IPC: A23K3/03
Filed: 1976-10-19
Abstract: 1505388 Preservative and use thereof in animal food B P CHEMICALS Ltd 20 Oct 1976 [27 Nov 1975] 48779/75 Headings A2B and A2D A liquid composition comprises in aqueous solution a complex acid salt of ammonium ions and/or ions of a metal selected from Group I and Group II of the Periodic Table due to Mendeleef, at least one carboxylic acid selected from formic acid, propionic acid, nbutyric acid, iso-butyric acid, 2-methyl butyric acid, valeric acid, levaleric acid, acrylic acid, and methacrylic acid, and water, the ratio of acid to ammonium and/or the metal ions being in the range of 2:1 and 4:1 on a chemical equivalent basis and the concentration of water in the aqueous solution being between 15 and 75% by wt. The metal ions are preferably one of sodium, potassium, calcium or magnesium. The liquid composition suitably contains at least one complex salt selected from ammonium dipropionate, ammonium diformate, sodium dipropionate, potassium dipropionate, calcium tetrapropionate, magnesium tetrapropionate. ammonium dibutyrate and ammonium diisobutyrate. The composition is suitable for use as a preservative for animal foodstuffs and agricultural crops.
[GB1505388A]
Patent IE-872938-L (IE)
Title: Small particle aerosol liposome and lipsome-drug combination
IPC: A61K9/127
Filed: 1987-10-30
Abstract: Disclosed are small particle aerosol liposome and liposome-drug combinations advantageous for the treatment of a wide variety of diseases. Different methods of preparation of liposome and liposome-drug combinations are described which can be used in small particle aerosol treatment.